Liguefaction in the Prevention of Posterior Capsule Opacification - Safety and Efficacy

Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00179906%3A_____%2F13%3A10173686" target="_blank" >RIV/00179906:_____/13:10173686 - isvavai.cz</a>
Result on the web
<a href="http://www.omicsonline.org/liquefaction-in-the-prevention-of-posterior-capsule-opacification-safety-and-efficacy-2155-9570.1000262.php?aid=10891" target="_blank" >http://www.omicsonline.org/liquefaction-in-the-prevention-of-posterior-capsule-opacification-safety-and-efficacy-2155-9570.1000262.php?aid=10891</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.4172/2155-9570.1000262" target="_blank" >10.4172/2155-9570.1000262</a>

Result language
angličtina
Original language name
Liguefaction in the Prevention of Posterior Capsule Opacification - Safety and Efficacy
Original language description
A prospective clinical trial comparing the extent of posterior capsule opacification (PCO) following cataract surgery with liquefaction method (AquaLase) as a prevention of PCO in the right eye. The AquaLase method was safe for ocular tissue. Statistically insignificant better results in the extent of PCO in eyes with AquaLase were observed.
Czech name
—
Czech description
—

Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FF - ENT (ie. ear, nose, throat), ophthalmology, dentistry
OECD FORD branch
—

Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Publication year
2013
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Similar results(10)